Login
English
Select your language
Close
bg
български
es
español
cs
čeština
da
dansk
de
Deutsch
et
eesti
el
ελληνικά
en
English
fr
français
ga
Gaeilge
hr
hrvatski
it
italiano
lv
latviešu
lt
lietuvių
hu
magyar
mt
Malti
nl
Nederlands
pl
polski
pt
português
ro
română
sk
slovenčina
sl
slovenščina
fi
suomi
sv
svenska
Search
Search
Search
Kohesio: discover EU projects in your region
Menu
Close
Menu
Back
Home
Projects
Beneficiaries
Services
Home
>
Beneficiaries
>
Beneficiary Details
Graph
More
more info
Start date:
1 November 2016
End date:
30 September 2023
Number of projects:
5
Total budget:
635 213,36 €
EU contribution:
480 582,60 €
Website:
n/a
Country:
funds
ERDF:
480 582,60 €
MEDICAL INVENTI SPÓŁKA AKCYJNA
share on
Facebook
Twitter
Linkedin
Email
report an issue
Open
PROJECTS
1 - 5 of 5
PROJECT
TOTAL BUDGET
EU CONTRIBUTION
FUND
Implementation of an innovative technology for the production of a legally protected invention called: “Bioactive Composite and Method of Manufacture of Bioactive Composite”
334 561,50 €
229 747,05 €
ERDF
Participation in the programme of promotion of the medical equipment industry means to increase the recognition of the brand of bone replacement biocomposite FlexiOss. “artificial bone.”
122 420,61 €
104 057,52 €
ERDF
Purchase of a service consisting of the PRECTION OF TECHNOLOGIC PROCESSING PRODUCTION of a legally protected invention called: ‘Bionic Composite and Bioactive Composite’ (Decision of the Patent Office of the Republic of Poland of 5 March 2010, category and number of protection: WYN: (11) 206394), “Bioactive composite and process for the production of the bioactive composite” (European pa
88 519,86 €
70 815,89 €
ERDF
Support Medical Inventi S.A. in preparing the feasibility phase and application for the EIC Accelerator Pilot programme
62 257,34 €
62 257,34 €
ERDF
Protection of industrial property rights of a machine for mass forming and production of ceramic composites.
27 454,05 €
13 704,80 €
ERDF
Visualise as a network
Open in the EU Knowledge Graph
Share on Facebook
Share on Twitter
Share on Linkedin
Share by Email
Report an issue by email